Literature DB >> 31203427

Highly aligned and geometrically structured poly(glycerol sebacate)-polyethylene oxide composite fiber matrices towards bioscaffolding applications.

Daniel O'Brien1, Andrew Hankins1, Nady Golestaneh2, Makarand Paranjape3.   

Abstract

The biocompatible and biodegradable polymer poly(glycerol sebacate), or PGS, is a rubber-like material that finds use in several biomedical applications. PGS is often cast into a mold to form desired structures; alternatively, blending PGS with other reinforcing polymers produces viscous solutions that can be spun into non-woven fibrous scaffolds. For tissue scaffolding applications, ordered fibrous matrices are advantageous and have been shown to promote cell orientation and proliferation by contact guidance, providing topographical cues for the seeded cells. The development of techniques for easily producing aligned fibrous matrices is therefore a priority. PGS nanofibers have been fabricated successfully using electrospinning techniques. For producing PGS microfibers, we introduce the electro-less STRAND (Substrate Translation and Rotation for Aligned Nanofiber Deposition) process as an alternative to electrospinning. STRAND provides superior control of fiber properties including diameter, alignment, spacing, and therefore deposition density by mechanically drawing polymer fibers from solution. The goal in using this method is the simple production of aligned PGS fiber matrices for retinal tissue scaffolding.

Entities:  

Keywords:  Aligned scaffold; Biocompatible polymer; Biomedical; Poly(glycerol sebacate); Tissue engineering

Year:  2019        PMID: 31203427     DOI: 10.1007/s10544-019-0402-0

Source DB:  PubMed          Journal:  Biomed Microdevices        ISSN: 1387-2176            Impact factor:   2.838


  1 in total

1.  Poly(Glycerol Sebacate)-Poly(l-Lactide) Nonwovens. Towards Attractive Electrospun Material for Tissue Engineering.

Authors:  Piotr Denis; Michał Wrzecionek; Agnieszka Gadomska-Gajadhur; Paweł Sajkiewicz
Journal:  Polymers (Basel)       Date:  2019-12-16       Impact factor: 4.329

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.